RSW.L – Renishaw – quick profile

Basic stats

EPIC      "RSW" "EPIC"
NAME  "RENISHAW" "Company name"
PER0       15.9 "Curr PER"
PE20      15.75 "PER10 P20"
PE50       18.1 "PER10 P50"
PE80      24.75 "PER10 P80"
OPMM       16.4 "OPM median"
YLD        2.71 "Yield (%)"
Z          7.98 "Z Score"
MKT       979.0 "MKT CAP (£m)"
ROE0       31.9 "Current ROE"
ROE10      15.5 "ROE median"
SP       1344.5 "Share Price (p)"
GRATE     18.92 "Graham EPS growth rate%"
XRATE     10.99 "Exp-fit EPS growth rate%"
SREPS      0.35 "Spearman rank of EPSa"
UPD   "Last Updated: Fri 23 Mar 2012" "Updated on Sharelock"

Google finance decription:

Renishaw plc is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products. The Company operates in two segments: metrology and healthcare products. Products available include laser tool setters, contact tool setters, tool breakage detectors, touch probes and high accuracy inspection probes. It offers medical devices, surgical robots and planning software for use in stereotactic neurosurgery for procedures. During the fiscal year ended June 30, 2011 (fiscal 2011), it acquired a 49% interest in Measurement Devices Limited (MDL), and acquired the remaining minority shareholding in PulseTeq Limited, increasing its shareholding to 100%. On April 8, 2011, it acquired a 100% interest in MTT Investments Limited (MTT). On June 16, 2011, the Company acquired a 100% interest in Aberlink Limited.

"Metrology" is "the science of measurement. So, measurement equipment.

"Spectroscopy" is "the study of the interaction between matter and radiated energy". Radiative energy can take the form of electromagnetic, particles (e.g. electrons and neutrons), acoustic, or mechanical.

Stereotactic is "a minimally invasive form of surgical intervention which makes use of a three-dimensional coordinate system to locate small targets inside the body and to perform on them some action such as ablation, biopsy, lesion, injection, stimulation, implantation, radiosurgery (SRS) etc."

Half-yearly report issued on 25-Jan-2012:

Revenue up 11%. Increased R&D ro support growth. Growth in marketing and distribution infrastructure. Further investment in manufacturing capacity. Established a new subsidiary in Mexico. The outlook for continuing global investment for production systems in automotive, civil aviation, agriculture and energy (including oil, gas and renewables) looks increasingly favourable.

Powered by Blogilo

About mcturra2000

Computer programmer living in Scotland.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s